What is the role of the clinical laboratory in the new ACC/AHA guidelines for the treatment of blood cholesterol in adults?
From the Laboratory of Atherosclerosis and Metabolic Research, Department of Pathology and Laboratory Medicine, and Division of Endocrinology, Metabolism and Diabetes, Department of Internal Medicine, University of California at Davis, and VA Medical Center, Sacramento, CA.
Ishwarlal
I
Jialal
D000328:Adult; D000368:Aged; D000572:American Heart Association; D002309:Cardiology / Q000592:standards*; D002318:Cardiovascular Diseases / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D006937:Hypercholesterolemia / Q000188:drug therapy*; D007753:Laboratories / Q000592:standards*; D008875:Middle Aged; D017410:Practice Guidelines as Topic; D012955:Societies, Medical; D014481:United States
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D002784:Cholesterol